LeukoTreat is a European project funded by the European Commission under the 7th Framework Programme for Research and Development.
The project aims at developing therapeutic strategies for the largest number of leukodystrophy (LD) affected patients as well as the development of further applications to more common white matter disorders and neurodegenerative diseases.
Launched in 2010, LeukoTreat gathers 24 partners from 8 different countries. The project combines the expertise of recognized European research teams in the field of white matter diseases, high-technology SMEs, experts in medical ethics and LD patients and families associations.
As the project reaches its end, the LeukoTreat partners are organizing the project’s final conference, which will be held at the Estrel Convention Center in Berlin on July 2d, 2013. The conference, which is open to the public, will present and discuss the research findings of the project. Anyone interested in the subject is more than welcome to join. The conference is free of charge but registration is required.
website: www.leukotreat.eu
